by University of California – San Diego 3D print of a spike protein of SARS-CoV-2, the virus that causes COVID-19–in front of a 3D print of a SARS-CoV-2 virus particle. The spike protein (foreground) enables the virus to enter and infect human cells. On the virus model, the virus surface (blue) is covered with spike proteins...
Author Julie Walsh-Messinger, Assistant Professor of Psychology, University of Dayton Disclosure statement Julie Walsh-Messinger does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment. Editor’s note: Julie Walsh-Messinger is a clinical psychologist who studies the...
by Case Western Reserve University Credit: CC0 Public Domain A study led by Case Western Reserve University researchers found that patients with dementia were at a significantly increased risk for COVID-19—and the risk was higher still for African Americans with dementia. Reviewing electronic health records of 61.9 million adults in the United States, researchers found the risk of...
MEMORIAL SLOAN KETTERING CANCER CENTER One of the dozens of unusual symptoms that have emerged in COVID-19 patients is a condition that’s informally called “COVID brain” or “brain fog.” It’s characterized by confusion, headaches, and loss of short-term memory. In severe cases, it can lead to psychosis and even seizures. It usually emerges weeks after...
By Clare Knight, B.Sc. Reviewed by Sophia Coveney, B.Sc. A novel coronavirus that was first reported in China in December 2019 quickly led to a global pandemic. Named COVID-19, the virus has had a devastating effect on economies and healthcare systems worldwide. Whilst highly contagious between humans, evidence of transmission from animals to humans is limited, although human...
A new study reveals that the blood of people who received two doses of the Pfizer-BioNTech vaccine contains high levels of antibodies that can neutralize one of the new, more contagious variants of SARS-CoV-2. Share on Pinterest MARK LENNIHAN/Getty Images Scientists first detected a new, more contagious variant of SARS-CoV-2, which is the virus that causes...
by University Health Network Single shot of peginterferon-lambda accelerates clearance of COVID-19 infection, UHN-led study shows. Credit: UHN A clinical study led by Dr. Jordan Feld, a liver specialist at Toronto Centre for Liver Disease, University Health Network (UHN), showed an experimental antiviral drug can significantly speed up recovery for COVID-19 outpatients—patients who do not need...
by University of Nottingham Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Credit: NIAID Researchers from the University of Nottingham have discovered a novel antiviral property of a drug that could have major implications in how future epidemics / pandemics—including COVID-19—are...
by The Scripps Research Institute Kendall Nettles, Ph.D., a molecular biologist at Scripps Research, Florida, collaborated with experts in many disciplines to systematically improve the safety of glucocorticoids. Credit: Scripps Research A collaboration led by Scripps Research has developed a way to separate the beneficial anti-inflammatory properties of a group of steroids called glucocorticoids from some of their unwanted side-effects, through an...
by Hunter Medical Research Institute, Hunter Medical Research Institute Researchers were able to use cells from human donors and re-grow the structure of the airway surface, the epithelium, to recreate the first line of defense against respiratory viruses. This model of the human airway was key to researchers showing that INNA-X can directly activate your airway epithelium so that it is better prepared...
